Proton versus photon therapy for esophageal cancer - A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancerH. R. Mortensen,P. Populaire,L. Hoffmann,D. S. Moeller,A. Appelt,P. Nafteux,C. T. Muijs,C. Grau,M. A. Hawkins,E. G. C. Troost,G. Defraene,R. Canters, C. S. Clarke,D. C. Weber,E. W. Korevaar,K. Haustermans,M. Nordsmark,Val Gebski,M. P. Achiam,Sheraz R. Markar,Ganesh Radhakrishna,Maaike Berbee,Daniele Scartoni,Ester Orlandi,Jerome Doyen,Vincent Gregoire,Gilles Crehange,Johannes Langendijk,Paula Lorgelly, Hedwig M. Blommenstein,Camilla S. Byskov, Mai L. Ehmsen,Maria Fuglsang Jensen,Gloria Vilches Freixas, Rebecca BuetoftRADIOTHERAPY AND ONCOLOGY（2024）Cited 0|Views29AI Read ScienceMust-Reading TreeExampleGenerate MRT to find the research sequence of this paperChat PaperSummary is being generated by the instructions you defined
